Pemphigus vulgaris is an autoimmune blistering disease that is induced by binding of antibodies to a 130/85-kD protein complex on epidermal keratinocytes. An in vivo experimental model of this disease was developed by reconstituting severe combined immunodeficiency (SCID) mice with 1-10 X 10' PBL from patients with naturally occurring pemphigus vulgaris. Of 49 reconstituted mice, 34 (69%) produced human IgG levels of > 0.1 mg/ml. Circulating anti-pemphigus antibodies were found in 20 of the 34 successfully reconstituted mice; 44% of these animals had deposits of human IgG in their own skin after it was traumatized by either heat or cold. Spontaneous pemphigus vulgaris-like blisters associated with human IgG deposits were rarely found in mouse skin. By contrast, allogeneic human skin grafted to 10 of 12 mice before reconstitution with patients' PBL developed pemphigus vulgaris-like lesions containing human IgG deposits. These results demonstrate that SCID mice can serve as a model of an antibody-mediated human autoimmune skin disease. (J. Clin. Invest. 1993.92:2401-2407
Introduction
Pemphigus vulgaris (PV)' is an autoimmune disease of skin and mucous membranes. Because of severe and extensive blistering, the disease can be fatal if untreated. It is mediated by antibodies to an epithelial-specific, intercellular antigen found in the suprabasal epidermis and mucosal epithelial layer. The PV antigen is a 130-kD glycoprotein ( 1) which is disulfidelinked to the 85-kD placoglobin (2) . cDNA cloning has recently identified the PV antigen as a member of the cadherin family of Ca2+-dependent cell adhesion molecules (3) . Blister formation after antibody binding to the PV antigen might be related to antibody inhibition of cadherin interactions (4) and may involve activation ofthe complement cascade (5) and/or plasminogen activators (6) .
Current experimental animal models for studies on the pathogenesis ofPV are based on the passive transfer ofpatients' Ig to newborn mice (7) or of patients' sera to athymic nude mice engrafted with human oral mucosa (8) . In the mucosal graft model, the incidence of epithelial cell detachment is low (3 of 25 grafts). Newborn mice injected with IgG fractions from pemphigus patients develop cutaneous blisters within I to 3 d. The lesions disappear after discontinuation of IgG injections and repeated injections ofadult mice with patients' Ig are without a pathogenic effect.
The availability of severe combined immunodeficiency (SCID) mice, which lack both functional B and T lymphocytes (9, 10) , makes continuous production of human Ig in the murine host possible. In SCID mice grafted with human fetal liver and thymus cells ( 1 1 ) or PBL ( 12) , the human cells home to lymphatic organs, thus reconstituting elements of the human immune system. Production ofhuman Ig is seen after 2 to 4 wk and remains detectable over 20 wk after engraftment. Lymphocytes from patients with autoimmune diseases such as systemic lupus erythematosus and biliary cirrhosis can be expanded in the murine host to reproduce the human disease ( 13, 14) .
Lymphocytes from patients with pemphigus produce autoantibodies against epidermal and mucosal antigens ( 15 ) . Because the human antibodies also bind to antigens on mouse keratinocytes ( 1, 16) , we investigated the effect of continuous antibody exposure on keratinocytes on the development ofPVlike disease in adult mice. Although SCID mice reconstituted with PBL from patients with PV rarely developed blisters in skin or mucous membranes, reconstituted mice that were previously grafted with full-thickness human skin developed PVlike blisters in the human grafts. Thus Circulating PV antibodies in the plasma of reconstituted SCID mice were detected by indirect immunofluorescence assays on frozen sections ofesophagus from African Green monkeys. For comparison of various substrates, air-dired sections of monkey esophagus, human skin, and murine skin were incubated with serial dilutions (1:10 to 1:320) ofplasma from PV patients for 30 min, washed in PBS, pH 7.3, for 10 min, and further incubated for 30 min with FITC-labeled goat IgG anti-human IgG. Slides were then covered with Fluoromount-G mounting medium (Fisher Scientific, Philadelphia, PA) and sealed. Sections were evaluated in a Leitz fluorescence microscope equipped with epi-illumination (Leitz USA, Deerfield, IL). PV antibodies in the epidermis stain in a typical cobblestone cell membrane pattern specific for this disease, allowing the routine clinical use of this assay for diagnosis.
For detection of human IgG in skin and mucous membranes by direct immunofluorescence, tissues were snap-frozen in OCT compound. Sections (5 gm) were air-dried for 1 h, fixed in 95% ethanol, and incubated for 30 min with FITC-conjugated goat IgG anti-human IgG. Slides were then washed and mounted. Portions of tissues (liver, lungs, spleen, pancreas, kidney, and lymph nodes) were fixed in 10% buffered formaldehyde for histopathological examinations. Sections (4 ,um) were stained with hematoxylin and eosin and analyzed under an Ortholux universal microscope (Leitz USA).
To facilitate human Ig deposition, dorsolateral skin ofanesthetized mice was traumatized 8 wk after reconstitution with PBL. A metal spatula immersed into liquid N2 was applied onto different sectors of the skin for 2, 5, and 15 s, respectively, in a 5-cm2 area previously treated with Zip Wax depilatory (Lee Pharma, El Monte, CA). A spatula, heated in water to 60°C, was then applied in three different sectors of the skin for 15, 30, and 60 s, respectively. Mice were sacrificed 24 h later and biopsies were obtained for histological and immunofluorescence assays.
Immunoprecipitation of PV antigen by antibodies in human and mouse plasma was done as described (1) Fig. 1 ). The mean IgG levels were higher if mice were reconstituted with 5-10 x 107 PBL/ mouse than with 1-2.5 x 107 PBL/mouse (16.6 mg/ml vs. 7.94 mg/ml, respectively). Human IgG was detected as early as 3 wk after reconstitution and, in individual mice tested, for at least 24 wk. Mice with IgG levels of 10 mg/ml or more often subsequently developed abdominal lymphomas (Fig. 1) . 5 out of 37 mice ( 13.5%) reconstituted with 1-2.5 x 107 PBL and 5 out of 12 mice (41.6% ) reconstituted with 5-10 x 107 PBL had clinically or histologically confirmed lymphomas. Focal hepatic infiltration ( 19) was seen in 5 out of 37 mice ( 13.5%) injected with 1-2.5 x 107 and 8 out of 12 (66%) mice injected with 5 x 107 PBL (data not shown). Due to the higher inci- mice (58%) that produced human IgG also had circulating antibodies with a PV-like binding pattern on tissue sections of monkey esophagus. The staining pattern in plasma from SCID mice reconstituted with PV patients' PBL was similar to that of patients' plasma ( Fig. 2 A and B) whereas plasma from healthy donors or from mice reconstituted with PBL from normal donors did not stain tissue (Fig. 2 C and D) nor did plasma of mice injected with normal human IgG (not shown). The presence ofanti-PV antibodies in the plasma ofreconstituted mice was confirmed in immunoprecipitation experiments with epithelial cells as antigen source (Fig. 3) . Antibodies in plasma of reconstituted mice and plasma/sera of PV patients bound the 1 30-kD PV antigen and co-precipitated the 85-kD placoglobin.
Spontaneous human IgG deposits in mouse skin associated with suprabasal acantholytic blister formation were occasionally observed (Fig. 4 A) . Ofthe reconstituted mice in which the skin was traumatized by heat or cold (see protocol), 21 (44%) showed skin IgG deposits adjacent to the site of trauma (Fig. 4   B) . By contrast, neither mice reconstituted with PBL from healthy donors (Fig. 4 C) nor those injected with human IgG (not shown) showed specific deposits in skin after traumatization.
Blistering disease in reconstituted SCID mice grafted with human skin. Human skin is the natural substrate for human anti-pemphigus antibodies in contrast to skin from adult mice. To determine whether human anti-pemphigus antibodies induce blister formation more readily in human than in mouse skin, 1.5 to 2 cm2 full-thickness human skin grafts were applied to the lateral abdomen ofSCID mice ( Fig. 5 A) ; and 4 wk later, 16 mice were reconstituted with 2.5-3 x 107 PBL from patients with PV or from normal donors (Table II) . 16 to 33 d later, mice reconstituted with patients' PBL developed lesions in the grafted human skin that varied from 3-mm erosions to denudation and crusting ofthe grafts (Fig. 5 B) . Histologically, the skin adjacent to erosions showed intraepidermal cell dyshesion, with rounded acantholytic cells (Fig. 5 C) . PV Discussion SCID mice reconstituted with PBL from pemphigus patients had circulating anti-pemphigus antibodies. These antibodies rarely induced spontaneous blisters in mouse skin but consistently bound to epidermal keratinocytes after the skin was mildly traumatized by heat or cold. SCID mice first grafted with full-thickness human skin, which were then reconstituted with pemphigus patients' PBL, consistently had human antibody deposits in the human grafts that were often associated with spontaneous blistering 18 to 33 d after reconstitution.
Although the staining pattern of human anti-pemphigus antibodies in mouse skin was similar to that in human skin, PV antigen appears expressed in greater amounts on human than on mouse skin. Possibly, human antibodies recognize epitopes on the PV antigen that are masked or absent on the murine antigen. The human PV antigen has recently been identified as a member of the cadherin family (3) ( 19) . SCID mice reconstituted with human PBL showed little evidence ofgraft-vs.-host disease and studies by others indicate varied reactions, ranging from lymphocytic infiltration around hepatic bile ducts (12, 13) to focal liver necrosis (20) . We observed only focal infiltrates ofCD45-positive cells in livers in 13 of 49 mice (data not shown). The observed variation of human IgG levels in reconstituted mice is consistent with previous studies (13, 21, 22) . Mice with high IgG levels (> 15 mg/ml) often developed lymphomas, which are commonly found in SCID mice reconstituted with PBL from EBV-positive donors (23) . The time course ofEBV-induced lymphomas varies depending on the percentage ofEBV-positive cells in the total lymphocyte population and the total injected dose ( 12) . To delay lymphoma development, we restricted the number of injected PBL to 2-3 X I0' per mouse and completed the experiments 8 wk after reconstitution.
The routine screening of mice for "leakiness," i.e., spontaneous IgM production, at 6 to 8 wk of age and the use of mice under the age of 12 wk helped prevent failures in reconstitution (24) . Transplantation of human skin (25) in our laboratory was successful in 90% of more than 200 transplantations ifthe grafted human foreskin was used no later than 2 d after resection and if the adult skin showed no evidence of trauma from handling during surgery. We detected no obvious graft-vs.-graft reactions despite the use ofallogeneic skin in these experiments in reconstituted mice. It remains to be determined whether any inflammatory reactions due to possible histoincompatibility of human PBL and skin contributes to blister development in this model. Autologous skin grafts from pemphigus patients were not done due to ethical considerations.
Models in experimental animals that closely mimic human antibody-mediated autoimmune diseases are rare. The animal model described here closely represents the naturally occurring disease because it involves both antibody-producing lymphocyte effector cells and epidermal keratinocytes (target cells) of human origin. Studies using this model can begin to address the questions that remain concerning the effector mechanisms of PV blister formation, the clonality of the antibody response in PV patients, and the identification ofimmunodominant epi-topes on the PV antigen. The recent cloning of the PV antigen (3) should aid in epitope mapping efforts. The SCID model for PV should also be useful in developing new therapeutic approaches that go beyond the current symptomatic treatment with corticosteroids.
